Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Hypoxia-inducible factor 1 in autoimmune diseases.
Age-specific localization of NMDA receptors on oligodendrocytes dictates axon function recovery after ischemia.
Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
[Epidemiology of multiple sclerosis].
[Phenotypes of Charcot-Marie-Tooth Syndrome and Differential Diagnosis Focused in Inflammatory Neuropathies].
Fluctuating neurological symptoms in demyelinating disease mimicking an acute ischaemic stroke.
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy.
Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.
Decreased TNF Levels and Improved Retinal Ganglion Cell Survival in MMP-2 Null Mice Suggest a Role for MMP-2 as TNF Sheddase.
Targeting specific cells in the brain with nanomedicines for CNS therapies.
A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
Role of Sortilin in Models of Autoimmune Neuroinflammation.
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
Neurourologic dysfunction: evaluation, surveillance and therapy.
Viral vectors for therapy of neurologic diseases.
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Therapy of NMO spectrum disorders.
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
Fatigue and heat sensitivity in patients with multiple sclerosis.
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.

Pages